Inipharm Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $35M

  • Investors
  • 4

Inipharm General Information

Description

Developer of a biopharmaceutical technology designed to discover and develop treatments for severe liver diseases. The company's technology is based on research focused on small molecules to target the activity of HSD17B13, a genetically defined target for multiple severe liver and related diseases, enabling the hospital industry to treat severe liver disease and reduce levels of liver damage, including inflammation and fibrosis.

Contact Information

Website
www.inipharm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500, 108th Avenue NorthEast
  • Suite 1100
  • Bellevue, WA 98004
  • United States
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 500, 108th Avenue NorthEast
  • Suite 1100
  • Bellevue, WA 98004
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Nov-2020 $35M Completed Startup
To view Inipharm’s complete valuation and funding history, request access »

Inipharm Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Inipharm’s complete cap table history, request access »

Inipharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical technology designed to discover and develop treatments for severe liver diseases. The c
Biotechnology
Bellevue, WA

Mont-Saint-Guibert, Belgium
 

Grand Rapids, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inipharm Competitors (2)

One of Inipharm’s 2 competitors is Cellaion, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Cirius Therapeutics Venture Capital-Backed Grand Rapids, MI
You’re viewing 2 of 2 competitors. Get the full list »

Inipharm Patents

  • 57

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Inipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260193218-A1 Hsd17b13 inhibitors and uses thereof Pending 19-Sep-2024
WO-2026064458-A1 Hsd17b13 inhibitors and uses thereof Pending 19-Sep-2024
WO-2025024682-A1 Methods of using dichlorophenol hsd17b13 inhibitors Inactive 26-Jul-2023
US-20250100993-A1 2-substituted thiazole hsd17b13 inhibitors and uses thereof Pending 17-May-2022
US-20250320186-A1 Hsd17b13 inhibitors and uses thereof Pending 17-May-2022 C07D249/18
To view Inipharm’s complete patent history, request access »

Inipharm Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
5AM Ventures Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
Jubilant Pharmova Corporation Minority
Platanus Family Office Minority
To view Inipharm’s complete investors history, request access »

Ready to get started?

Request a free trial

Inipharm FAQs

  • When was Inipharm founded?

    Inipharm was founded in 2018.

  • Where is Inipharm headquartered?

    Inipharm is headquartered in Bellevue, WA.

  • What industry is Inipharm in?

    Inipharm’s primary industry is Biotechnology.

  • Is Inipharm a private or public company?

    Inipharm is a Private company.

  • What is the current valuation of Inipharm?

    The current valuation of Inipharm is .

  • What is Inipharm’s current revenue?

    The current revenue for Inipharm is .

  • How much funding has Inipharm raised over time?

    Inipharm has raised $35M.

  • Who are Inipharm’s investors?

    5AM Ventures, Frazier Healthcare Partners, Jubilant Pharmova, and Platanus have invested in Inipharm.

  • Who are Inipharm’s competitors?

    Cellaion and Cirius Therapeutics are competitors of Inipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process